Please login to the form below

Not currently logged in

AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer


Approximately 7,400 new cases of the disease are diagnosed in the UK every year

Novartis’ Fabhalta approved by FDA as first oral monotherapy for rare blood disease PNH

Novartis buildingThe rare blood disease is estimated to affect only ten to 20 people per million worldwide

EC approves UCB’s Zilbrysq as generalised myasthenia gravis add-on therapy

EU flagThe autoimmune disease has a global prevalence of 100 to 350 cases per every one million people

Eli Lilly’s Jaypirca granted FDA accelerated approval for non-Hodgkin lymphomas

Approximately 18,740 new cases of CLL have been diagnosed in the US this year

Pfizer’s RSV vaccine granted MHRA approval to protect infants and older adults

Pfizer NY headquartersRSV is associated with 15,000 hospital admissions in infants under six months every year in England

Novavax’s updated COVID-19 vaccine granted Emergency Use Listing by WHO

Nuvaxovid XBB.1.5 is now approved for emergency use in all 194 WHO member states

FDA to investigate risk of T-cell malignancy from CAR-T cell immunotherapies

The regulator will monitor approved BCMA- or CD19-directed autologous CAR-T cell immunotherapies

FDA approves SpringWork’s Ogsiveo as first therapy for desmoid tumours

Approximately 1,650 people in the US are diagnosed with the rare non-cancerous tumours each year

AstraZeneca's rare disease unit receives NICE recommendation for Wolman disease therapy in infants

AZ NEWThe enzyme replacement therapy will become the first treatment available on the NHS for the rare genetic disease

Brexit‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe

Latest regulatory appointments

Subscribe to our email news alerts


Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
New Playbook Alert: Virtual Patient Engagement
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...